Trials / Unknown
UnknownNCT04971135
First-in-human Study of SAN711 in Healthy Participants
A Phase 1 Study to Assess the Safety and Tolerability of Single and Multiple Ascending Doses of SAN711 in Healthy Participants
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Saniona · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Phase 1, first-in-human, double-blind, randomized, placebo-controlled, parallel group, single ascending dose (SAD) and multiple ascending dose (MAD) study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SAN711 | SAN711 liquid formulation |
| OTHER | Placebo | Matching placebo |
Timeline
- Start date
- 2021-06-30
- Primary completion
- 2022-06-01
- Completion
- 2022-06-01
- First posted
- 2021-07-21
- Last updated
- 2021-07-21
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04971135. Inclusion in this directory is not an endorsement.